Sodium-glucose cotransporter-2 inhibitor therapy in kidney transplant patients with type 2 or post-transplant diabetes: an observational multicentre study

BACKGROUND: Sodium–glucose cotransporter-2 inhibitors (SGLT2is) have cardioprotective and renoprotective effects. However, experience with SGLT2is in diabetic kidney transplant recipients (DKTRs) is limited. METHODS: This observational multicentre study was designed to examine the efficacy and safet...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez Fructuoso, Ana I, Bedia Raba, Andrea, Banegas Deras, Eduardo, Vigara Sánchez, Luis A, Valero San Cecilio, Rosalía, Franco Esteve, Antonio, Cruzado Vega, Leonidas, Gavela Martínez, Eva, González Garcia, María E, Saurdy Coronado, Pablo, Morales, Nancy D Valencia, Zarraga Larrondo, Sofía, Ridao Cano, Natalia, Mazuecos Blanca, Auxiliadora, Hernández Marrero, Domingo, Beneyto Castello, Isabel, Paul Ramos, Javier, Sierra Ochoa, Adriana, Facundo Molas, Carmen, González Roncero, Francisco, Torres Ramírez, Armando, Cigarrán Guldris, Secundino, Pérez Flores, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229265/
https://www.ncbi.nlm.nih.gov/pubmed/37260993
http://dx.doi.org/10.1093/ckj/sfad007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229265/
https://www.ncbi.nlm.nih.gov/pubmed/37260993
http://dx.doi.org/10.1093/ckj/sfad007

Ejemplares similares